These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19587350)

  • 1. Long-acting beta-agonists in asthma.
    Agarwal A
    N Engl J Med; 2009 Jul; 361(2):208; author reply 209. PubMed ID: 19587350
    [No Abstract]   [Full Text] [Related]  

  • 2. The FDA and safe use of long-acting beta-agonists in the treatment of asthma.
    Chowdhury BA; Dal Pan G
    N Engl J Med; 2010 Apr; 362(13):1169-71. PubMed ID: 20181964
    [No Abstract]   [Full Text] [Related]  

  • 3. Balancing the benefits and risks of inhaled long-acting beta-agonists--the influence of values.
    Kramer JM
    N Engl J Med; 2009 Apr; 360(16):1592-5. PubMed ID: 19369665
    [No Abstract]   [Full Text] [Related]  

  • 4. PHARMAC responds on long-acting inhalers for COPD.
    Metcalfe S; Dougherty S
    N Z Med J; 2005 Nov; 118(1225):U1743. PubMed ID: 16286950
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA LABA warning: is there anything new here?
    Weiss ST
    Clin Pharmacol Ther; 2010 Jun; 87(6):638-9. PubMed ID: 20485319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL; Baker EL; Coleman CI
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined therapy ICS/LABA--new therapeutical trends in patients with asthma and chronic obstructive pulmonary disease].
    Chazan R
    Pol Merkur Lekarski; 2010 Apr; 28(166):251-5. PubMed ID: 20491331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risks and benefits of indacaterol--the FDA's review.
    Chowdhury BA; Seymour SM; Michele TM; Durmowicz AG; Liu D; Rosebraugh CJ
    N Engl J Med; 2011 Dec; 365(24):2247-9. PubMed ID: 22168640
    [No Abstract]   [Full Text] [Related]  

  • 9. Potential side effects in patients treated with inhaled corticosteroids and long-acting beta2-agonists.
    Korsgaard J; Ledet M
    Respir Med; 2009 Apr; 103(4):566-73. PubMed ID: 19136239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indacaterol Novartis/skyePharma.
    Currie GP
    Curr Opin Investig Drugs; 2006 May; 7(5):457-63. PubMed ID: 16729723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled beta 2-adrenergic agonists in asthma: the evolving dilemma.
    Hui KP
    Singapore Med J; 1994 Jun; 35(3):237-9. PubMed ID: 7997893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA imposes new rules for long-acting asthma drugs. Recent studies show that long-term use of LABAs alone may make asthma symptoms worse, not better.
    Duke Med Health News; 2010 May; 16(5):7. PubMed ID: 20518134
    [No Abstract]   [Full Text] [Related]  

  • 13. Benefits of long-acting beta2-agonists.
    Lipworth BJ
    J Allergy Clin Immunol; 2007 Sep; 120(3):725; author reply 726. PubMed ID: 17582480
    [No Abstract]   [Full Text] [Related]  

  • 14. [Rapid effectiveness and better medication compliance].
    Gessner C
    MMW Fortschr Med; 2014 Oct; 156(17):67. PubMed ID: 25417481
    [No Abstract]   [Full Text] [Related]  

  • 15. The FDA-mandated trial of safety of long-acting beta-agonists in asthma: finality or futility?
    Sears MR
    Thorax; 2013 Feb; 68(2):195-8. PubMed ID: 22858928
    [No Abstract]   [Full Text] [Related]  

  • 16. Survival with tiotropium compared to long-acting Beta-2-agonists in Chronic Obstructive Pulmonary Disease.
    Gershon AS; Wang L; To T; Luo J; Upshur RE
    COPD; 2008 Aug; 5(4):229-34. PubMed ID: 18671148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A new long-acting asthma spray. Preliminary wait-and-see attitude?].
    Flaten O
    Tidsskr Nor Laegeforen; 1993 May; 113(13):1610. PubMed ID: 8101664
    [No Abstract]   [Full Text] [Related]  

  • 18. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
    Ohar JA; Donohue JF
    Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combination of beta-1 agonist and corticosteroid is advantageous not only in asthma. COPD patients spared exacerbations].
    MMW Fortschr Med; 2002 Oct; 144(44):55. PubMed ID: 12494604
    [No Abstract]   [Full Text] [Related]  

  • 20. [New beta2-agonists in asthma and COPD].
    Chyrek-Borowska S; Rogalewska AM
    Pneumonol Alergol Pol; 2002; 70 Suppl 1():58-61. PubMed ID: 12580164
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.